These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17899837)

  • 21. Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy.
    Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Zhou H; Li LS
    Chin Med J (Engl); 2005 Apr; 118(7):555-60. PubMed ID: 15820086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Contribution of Japanese researchers to progress in studies on nephrology in the past 100 years: Lipoportein glomerulopathy].
    Saito T
    Nihon Naika Gakkai Zasshi; 2002 May; 91(5):1444-7. PubMed ID: 12082733
    [No Abstract]   [Full Text] [Related]  

  • 23. Etiological significance of apolipoprotein E mutations in lipoprotein glomerulopathy.
    Saito T; Ishigaki Y; Oikawa S; Yamamoto TT
    Trends Cardiovasc Med; 2002 Feb; 12(2):67-70. PubMed ID: 11852253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up of a paediatric case of lipoprotein glomerulopathy.
    Koitabashi Y; Ikoma M; Miyahira T; Fujita R; Mio H; Ishida M; Shimizu K; Sakaguchi H
    Pediatr Nephrol; 1990 Mar; 4(2):122-8. PubMed ID: 2397177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A 3-amino acid deletion of apolipoprotein E found in 3 Chinese lipoprotein glomerulopathy patients].
    Chen YQ; Zhang H; Zhu SL; Zou WZ; Wang M; Liu ZS; Wang HY
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):774-7. PubMed ID: 12899757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein E and familial dysbetalipoproteinemia: clinical, biochemical, and genetic aspects.
    Smelt AH; de Beer F
    Semin Vasc Med; 2004 Aug; 4(3):249-57. PubMed ID: 15630634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lipoprotein glomerulopathy].
    Watanabe T; Mitarai T
    Ryoikibetsu Shokogun Shirizu; 1997; (16 Pt 1):219-22. PubMed ID: 9277726
    [No Abstract]   [Full Text] [Related]  

  • 28. A patient with apolipoprotein E2 variant (Q187E) without lipoprotein glomerulopathy.
    Hayakawa M; Okubo M; Katori H; Nagahama K; Murase T; Kobayashi T; Tanaka S; Nakanishi K; Odawara M; Matsushita H; Yamada A
    Am J Kidney Dis; 2002 Mar; 39(3):E15. PubMed ID: 11877595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Apolipoprotein E phenotyping--useful in the study of hyperlipoproteinemia type III].
    Hagve TA; Furuset T; Christophersen B; Ose L
    Tidsskr Nor Laegeforen; 1993 Mar; 113(7):853-6. PubMed ID: 8480294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topics in lipoprotein glomerulopathy: an overview.
    Saito T; Matsunaga A; Ito K; Nakashima H
    Clin Exp Nephrol; 2014 Apr; 18(2):214-7. PubMed ID: 24149835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels.
    de Knijff P; van den Maagdenberg AM; Frants RR; Havekes LM
    Hum Mutat; 1994; 4(3):178-94. PubMed ID: 7833947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type III hyperlipoproteinemia with xanthomas and multiple myeloma.
    Burnside NJ; Alberta L; Robinson-Bostom L; Bostom A
    J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S281-4. PubMed ID: 16227109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Newer glomerular diseases.
    Abt AB; Cohen AH
    Semin Nephrol; 1996 Nov; 16(6):501-10. PubMed ID: 9125794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type III hyperlipoproteinemia: recent insights into the genetic defect of familial dysbetalipoproteinemia.
    Mahley RW; Angelin B
    Adv Intern Med; 1984; 29():385-411. PubMed ID: 6369930
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical and pathological analyses of lipoprotein glomerulopathy].
    Hu ZX; Zhang XH; Sha ZH; Yang LC; Huang SM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):442-4. PubMed ID: 15181857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia.
    Yamamura T; Yamamoto A; Sumiyoshi T; Hiramori K; Nishioeda Y; Nambu S
    J Clin Invest; 1984 Oct; 74(4):1229-37. PubMed ID: 6480826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoprotein glomerulopathy: a new role for apolipoprotein E?
    Karet FE; Lifton RP
    J Am Soc Nephrol; 1997 May; 8(5):840-2. PubMed ID: 9176856
    [No Abstract]   [Full Text] [Related]  

  • 38. [Type III hyperlipidemia].
    Nishiwaki M; Nakamura H
    Nihon Rinsho; 1990 Nov; 48(11):2546-51. PubMed ID: 2270019
    [No Abstract]   [Full Text] [Related]  

  • 39. Apolipoprotein E-associated Lipoprotein Glomerulo-tubulopathy.
    Tanimizu H; Hara R; Sekine A; Inoue N; Hasegawa E; Tanaka K; Kono K; Kinowaki K; Ohashi K; Okubo M; Yamaguchi Y; Kang D; Honda K; Saito T; Sawa N; Ubara Y; Hoshino J
    Intern Med; 2023; 62(15):2209-2214. PubMed ID: 37532513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Genetic abnormalities of plasma apolipoproteins].
    Yamamura T; Yamamoto A
    Rinsho Byori; 1986 Apr; 34(4):408-14. PubMed ID: 3747193
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.